Physician profile
Ronald B Boeding
NPI 1104093152
$67,907.94
in general payments reported to CMS, 2019-2025
22 companies · $27K in 2025
The $27K reported for 2025 was more than what 98% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $686 · 2020: $459 · 2021: $8,336 · 2022: $888 · 2023: $21K · 2024: $9,290 · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $33K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $9,083 · Travel and Lodging: $2,355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $33,200.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,900.00 |
| Food and Beverage | $9,083.48 |
| Travel and Lodging | $2,355.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $30,698.89 | 2022-2025 | Evoke, Evoke Scs |
| Boston Scientific Corporation | $17,449.18 | 2019-2025 | Wavewriter Alpha Prime 16, General - Therapies, Intracept |
| Abbvie INC. | $12,965.53 | 2023-2025 | Ubrelvy, Qulipta |
| Nevro Corp. | $1,672.79 | 2020-2024 | Senza |
| Medtronic, INC. | $1,094.40 | 2021-2025 | Intellis Adaptivestim, Venaseal, Inceptiv |
| Spr Therapeutics, INC | $1,093.60 | 2023-2024 | Sprint Pns System |
| Abbott Laboratories | $733.16 | 2020-2025 | Proclaim |
| Medtronic USA, INC. | $494.14 | 2019-2020 | |
| Si-Bone, INC. | $472.36 | 2019-2025 | |
| Biotronik Nro, INC. | $316.32 | 2025 | Prospera |
| Relievant Medsystems, INC. | $263.51 | 2020-2023 | Intracept |
| Nalu Medical, INC. | $185.96 | 2024-2025 | Nalu Neurostimulation System |
| Vertos Medical, INC. | $177.08 | 2024 | Mild Device Kit |
| Curonix LLC | $120.04 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Teva Pharmaceuticals USA, INC. | $67.74 | 2019-2025 | Ajovy |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $35.19 | 2025 | Senza |
| Fidia Pharma USA INC. | $17.17 | 2024 | Hymovis |
| Biohaven Pharmaceuticals, INC. | $13.54 | 2021 | |
| Amgen INC. | $12.50 | 2021 | |
| Biodelivery Sciences International, INC. | $11.99 | 2021 | |
| Collegium Pharmaceutical, INC. | $11.56 | 2020 | |
| Mml US, INC. | $1.29 | 2025 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Boeding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.